Apremilast therapy increases CD39<sup>+</sup>CD4<sup>+</sup> T cells in peripheral blood of patients with psoriatic disease: a retrospective observational pilot study. [PDF]
Mavropoulos A +6 more
europepmc +1 more source
Genetically predicted serum Pimelylcarnitine mediates the association between CD39+ secreting Treg cells and intervertebral disc degeneration. [PDF]
Li N +6 more
europepmc +1 more source
Purinergic activity of circulating extracellular vesicles associates with disease progression in melanoma. [PDF]
Najjar YG +6 more
europepmc +1 more source
Mass Cytometry Reveals Comparable Proportions of Leukocyte Subsets and Cell Surface P2X7 or CD39 on Human Peripheral Blood Mononuclear Cell Samples Isolated by Ficoll-Paque or SepMate Tube Density Gradient Centrifugation. [PDF]
Elhage A +6 more
europepmc +1 more source
CD39/CD73-mediated immunosuppression and tumor aggressiveness in bladder cancer. [PDF]
Furriel F +9 more
europepmc +1 more source
Caffeine-mediated CD39<sup>+</sup> Treg activation via the CD39-adenosine receptor pathway is a novel risk factor for pulmonary tuberculosis. [PDF]
Zhu L +17 more
europepmc +1 more source
The expression of CD39 on NK cells relates to poor HIV-1 suppression in treatment-naïve HIV-1-infected individuals: Association with elevated IL-10 secretion and TIGIT co-expression. [PDF]
Zhang X +12 more
europepmc +1 more source
Acute effects of a single electroacupuncture session on purinergic signaling and inflammatory markers in patients with chronic nonspecific low back pain: a pilot study. [PDF]
Ecco JC +7 more
europepmc +1 more source
Revisiting MSC heterogeneity: significance of the CD73<sup>+</sup>CD39<sup>+</sup>CD146<sup>+</sup> perivascular subset in bone marrow. [PDF]
Rajendran RL +3 more
europepmc +1 more source
CD39 in the pathogenesis of neuro-Behçet disease: is it an immune regulator marker? [PDF]
Bahrini K +3 more
europepmc +1 more source

